Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002223 · ClinicalTrials.gov registry record · NA
A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients
A NA study, sponsored by Abbott.
- Completed
- Registry status
- NA
- Development phase
NCT00002223: Completed NA study, sponsored by Abbott.
NCT00002223 is a NA study that has completed, run by Abbott. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002223, a NA study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to determine how many HIV-infected patients continue taking ritonavir/indinavir combination after having taken indinavir three times a day as part of their anti-HIV drug therapy. This study also examines the safety and effectiveness of the ritonavir/indinavir combination.
Interventions
- DRUG Ritonavir
- DRUG Indinavir sulfate
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002223 record still lists
NCT00002223 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Ritonavir is the first listed.
NCT00002223 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002223 about?
NCT00002223 is a clinical study titled "A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients". The purpose of this study is to determine how many HIV-infected patients continue taking ritonavir/indinavir combination after having taken indinavir three times a day as part of their anti-HIV drug therapy. This study also examines the safety and effectiveness of the ritonavir/indinavir combination...
What is the current status of trial NCT00002223?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002223?
The interventions under investigation include: Ritonavir (DRUG), Indinavir sulfate (DRUG).
Who is sponsoring clinical trial NCT00002223?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.